Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 17Pancreatic Neoplasms 11Carcinoma, Hepatocellular 10Colonic Neoplasms 7Rectal Neoplasms 6Ovarian Neoplasms 4Neoplasm Metastasis 4Cholangiocarcinoma 4Breast Neoplasms 4Prostatic Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Multiple Myeloma 2Lung Neoplasms 2Hematologic Neoplasms 2Gallbladder Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Turcot syndrome 1Thyroid Neoplasms 1Thrombocytosis 1Somatostatinoma 1Sarcoma 1Resectable Intrahepatic Cholangiocarcinoma 1Recurrence 1

Interventions

Temozolomide 3Capecitabine 3Trastuzumab 2Bevacizumab 2veliparib 1tipifarnib 1temsirolimus 1Sunitinib 1Specimen Handling 1Sirolimus 1Panobinostat 1Oxaliplatin 1Nivolumab 1Melphalan 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunoglobulin G 1Floxuridine 1Fentanyl 1Disulfides 1CTLA-4 Antigen 1Bortezomib 111-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Somatostatinoma × Disulfides × Gastrointestinal × Clear all
NCT01010126 2019-01-25

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

National Cancer Institute (NCI)

Phase 2 Completed
252 enrolled 20 charts
GastrointestinalGynecologic

Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Somatostatinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡